• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 KLHDC2 泛素 E3 连接酶靶向降解激酶。

Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase.

机构信息

KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea; Severance Biomedical Science Institute, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.

Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA 94305, USA.

出版信息

Cell Chem Biol. 2023 Nov 16;30(11):1414-1420.e5. doi: 10.1016/j.chembiol.2023.07.008. Epub 2023 Aug 10.

DOI:10.1016/j.chembiol.2023.07.008
PMID:37567174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10839117/
Abstract

Chemically induced protein degradation is a powerful strategy for perturbing cellular biochemistry. The predominant mechanism of action for protein degrader drugs involves an induced proximity between the cellular ubiquitin-conjugation machinery and a target. Unlike traditional small molecule enzyme inhibition, targeted protein degradation can clear an undesired protein from cells. We demonstrate here the use of peptide ligands for Kelch-like homology domain-containing protein 2 (KLHDC2), a substrate adapter protein and member of the cullin-2 (CUL2) ubiquitin ligase complex, for targeted protein degradation. Peptide-based bivalent compounds that can induce proximity between KLHDC2 and target proteins cause degradation of the targeted factors. The cellular activity of these compounds depends on KLHDC2 binding. This work demonstrates the utility of KLHDC2 for targeted protein degradation and exemplifies a strategy for the rational design of peptide-based ligands useful for this purpose.

摘要

化学诱导的蛋白质降解是一种用于扰乱细胞生物化学的强大策略。蛋白降解药物的主要作用机制涉及细胞泛素缀合机制与靶标之间的诱导接近。与传统的小分子酶抑制不同,靶向蛋白质降解可以从细胞中清除不需要的蛋白质。我们在这里展示了使用肽配体对 Kelch 样同源结构域蛋白 2 (KLHDC2)的应用,KLHDC2 是一种底物衔接蛋白,也是 cullin-2 (CUL2)泛素连接酶复合物的成员,用于靶向蛋白质降解。能够诱导 KLHDC2 与靶蛋白之间接近的基于肽的双价化合物会导致靶标因子的降解。这些化合物的细胞活性取决于 KLHDC2 的结合。这项工作证明了 KLHDC2 用于靶向蛋白质降解的实用性,并举例说明了用于该目的的基于肽的配体的合理设计策略。

相似文献

1
Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase.通过 KLHDC2 泛素 E3 连接酶靶向降解激酶。
Cell Chem Biol. 2023 Nov 16;30(11):1414-1420.e5. doi: 10.1016/j.chembiol.2023.07.008. Epub 2023 Aug 10.
2
Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules.小分子通过 KLHDC2 E3 连接酶实现靶向蛋白降解。
Nat Struct Mol Biol. 2024 Feb;31(2):311-322. doi: 10.1038/s41594-023-01146-w. Epub 2024 Jan 4.
3
Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2.利用 C 降解基序 E3 KLHDC2 进行旁系同源特异性靶向蛋白降解的原理。
Nat Commun. 2024 Oct 12;15(1):8829. doi: 10.1038/s41467-024-52966-3.
4
Identification of KLHDC2 as an efficient proximity-induced degrader of K-RAS, STK33, β-catenin, and FoxP3.鉴定 KLHDC2 为一种有效的 KRAS、STK33、β-catenin 和 FoxP3 的临近诱导降解物。
Cell Chem Biol. 2023 Oct 19;30(10):1261-1276.e7. doi: 10.1016/j.chembiol.2023.07.006. Epub 2023 Aug 16.
5
Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation.利用 Cullin E3 连接酶衔接蛋白 SKP1 进行靶向蛋白降解。
ACS Chem Biol. 2024 Feb 16;19(2):442-450. doi: 10.1021/acschembio.3c00642. Epub 2024 Feb 2.
6
E3 ligase autoinhibition by C-degron mimicry maintains C-degron substrate fidelity.E3 连接酶通过 C 降解结构域模拟物的自身抑制作用维持 C 降解结构域底物的保真度。
Mol Cell. 2023 Mar 2;83(5):770-786.e9. doi: 10.1016/j.molcel.2023.01.019. Epub 2023 Feb 16.
7
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.E3 连接酶配体用于 PROTACs:它们是如何被发现的,以及如何发现新的配体。
SLAS Discov. 2021 Apr;26(4):484-502. doi: 10.1177/2472555220965528. Epub 2020 Nov 3.
8
Discovery of E3 Ligase Ligands for Target Protein Degradation.E3 连接酶配体用于靶蛋白降解的发现。
Molecules. 2022 Oct 2;27(19):6515. doi: 10.3390/molecules27196515.
9
A synthetic KLHL20 ligand to validate CUL3 as a potent E3 ligase for targeted protein degradation.一种合成的 KLHL20 配体,用于验证 CUL3 作为一种有效的 E3 连接酶,用于靶向蛋白质降解。
Genes Dev. 2022 Sep 1;36(17-18):1031-1042. doi: 10.1101/gad.349717.122. Epub 2022 Nov 3.
10
Bifunctional Peptide Nanofibrils for Targeted Protein Degradation.双功能肽纳米纤维用于靶向蛋白降解。
Angew Chem Int Ed Engl. 2024 Jan 15;63(3):e202316581. doi: 10.1002/anie.202316581. Epub 2023 Dec 14.

引用本文的文献

1
Degrons: defining the rules of protein degradation.降解结构域:定义蛋白质降解的规则
Nat Rev Mol Cell Biol. 2025 Jul 14. doi: 10.1038/s41580-025-00870-z.
2
Targeted protein degradation by KLHDC2 ligands identified by high-throughput screening.通过高通量筛选鉴定的KLHDC2配体介导的靶向蛋白质降解
Elife. 2025 Jun 16;14:RP106844. doi: 10.7554/eLife.106844.
3
Characteristics of the Kelch domain containing (KLHDC) subfamily and relationships with diseases.含kelch结构域(KLHDC)亚家族的特征及其与疾病的关系。
FEBS Lett. 2025 Apr;599(8):1094-1112. doi: 10.1002/1873-3468.15108. Epub 2025 Jan 30.
4
Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2.利用 C 降解基序 E3 KLHDC2 进行旁系同源特异性靶向蛋白降解的原理。
Nat Commun. 2024 Oct 12;15(1):8829. doi: 10.1038/s41467-024-52966-3.
5
PROTAC-mediated activation, rather than degradation, of a nuclear receptor reveals complex ligand-receptor interaction network.PROTAC介导的核受体激活而非降解揭示了复杂的配体-受体相互作用网络。
Structure. 2024 Dec 5;32(12):2352-2363.e8. doi: 10.1016/j.str.2024.09.016. Epub 2024 Oct 9.
6
An artificial intelligence accelerated virtual screening platform for drug discovery.人工智能加速药物发现的虚拟筛选平台。
Nat Commun. 2024 Sep 5;15(1):7761. doi: 10.1038/s41467-024-52061-7.
7
Applications of protein ubiquitylation and deubiquitylation in drug discovery.蛋白质泛素化和去泛素化在药物发现中的应用。
J Biol Chem. 2024 May;300(5):107264. doi: 10.1016/j.jbc.2024.107264. Epub 2024 Apr 4.
8
The herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation.疱疹病毒 UL49.5 蛋白劫持细胞 C 降解途径以驱动 TAP 转运体降解。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2309841121. doi: 10.1073/pnas.2309841121. Epub 2024 Mar 5.
9
PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.PINK1-PTEN 轴通过非经典途径促进卵巢癌的转移和化疗耐药。
J Exp Clin Cancer Res. 2023 Nov 9;42(1):295. doi: 10.1186/s13046-023-02823-w.
10
E3 ligase autoinhibition by C-degron mimicry maintains C-degron substrate fidelity.E3 连接酶通过 C 降解结构域模拟物的自身抑制作用维持 C 降解结构域底物的保真度。
Mol Cell. 2023 Mar 2;83(5):770-786.e9. doi: 10.1016/j.molcel.2023.01.019. Epub 2023 Feb 16.

本文引用的文献

1
E3 ligase autoinhibition by C-degron mimicry maintains C-degron substrate fidelity.E3 连接酶通过 C 降解结构域模拟物的自身抑制作用维持 C 降解结构域底物的保真度。
Mol Cell. 2023 Mar 2;83(5):770-786.e9. doi: 10.1016/j.molcel.2023.01.019. Epub 2023 Feb 16.
2
Profiling of diverse tumor types establishes the broad utility of VHL-based ProTaCs and triages candidate ubiquitin ligases.对多种肿瘤类型进行分析确定了基于VHL的PROTAC的广泛实用性,并对候选泛素连接酶进行了分类。
iScience. 2022 Feb 26;25(3):103985. doi: 10.1016/j.isci.2022.103985. eCollection 2022 Mar 18.
3
PROTAC targeted protein degraders: the past is prologue.PROTAC 靶向蛋白降解剂:过去是序幕。
Nat Rev Drug Discov. 2022 Mar;21(3):181-200. doi: 10.1038/s41573-021-00371-6. Epub 2022 Jan 18.
4
Identification of Thieno[3,2-]pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and FMS-like Tyrosine Kinase 3.鉴定噻吩并[3,2-d]嘧啶衍生物为黏着斑激酶和 FMS 样酪氨酸激酶 3 的双重抑制剂。
J Med Chem. 2021 Aug 26;64(16):11934-11957. doi: 10.1021/acs.jmedchem.1c00459. Epub 2021 Jul 29.
5
Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders.WD-重复蛋白 5(WDR5)降解剂的设计、合成与评价。
J Med Chem. 2021 Aug 12;64(15):10682-10710. doi: 10.1021/acs.jmedchem.1c00146. Epub 2021 May 13.
6
Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide.基于靶向蛋白降解的癌症疗法——来那度胺的经验教训。
Nat Rev Clin Oncol. 2021 Jul;18(7):401-417. doi: 10.1038/s41571-021-00479-z. Epub 2021 Mar 2.
7
The C-degron pathway eliminates mislocalized proteins and products of deubiquitinating enzymes.C 降解途径可消除错误定位的蛋白质和去泛素化酶的产物。
EMBO J. 2021 Apr 1;40(7):e105846. doi: 10.15252/embj.2020105846. Epub 2021 Jan 20.
8
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development.绘制可降解激酶组图谱为加快降解剂开发提供资源。
Cell. 2020 Dec 10;183(6):1714-1731.e10. doi: 10.1016/j.cell.2020.10.038. Epub 2020 Dec 3.
9
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.E3 连接酶配体用于 PROTACs:它们是如何被发现的,以及如何发现新的配体。
SLAS Discov. 2021 Apr;26(4):484-502. doi: 10.1177/2472555220965528. Epub 2020 Nov 3.
10
Development and Characterization of a Wee1 Kinase Degrader.开发并鉴定一种 Wee1 激酶降解剂。
Cell Chem Biol. 2020 Jan 16;27(1):57-65.e9. doi: 10.1016/j.chembiol.2019.10.013. Epub 2019 Nov 14.